Want to join the conversation?
$R 1Q15 10-Q: Revenues were $1,567.15MM vs. $1,610.74MM in 1Q14. Net earnings were $52.92MM vs. $48.23MM in 1Q14. Operating revenue was $1,300.29MM vs. $1,242.77MM in 1Q14. Costs and expenses were $1,482.77MM vs. $1,535.73MM in 1Q14. Diluted earnings per share were $0.99 vs. $0.90 in 1Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?